Clinical data | |
---|---|
Trade names | Urecholine, others |
Other names | 2-[(aminocarbonyl)oxy]- N,N,N-trimethyl- 1-propanaminium Carbamyl-β-methylcholine |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682849 |
Routes of administration | By mouth, subcutaneous |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C7H17N2O2 |
Molar mass | 161.225 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Bethanechol is a parasympathomimetic choline carbamate that selectively stimulates muscarinic receptors without any effect on nicotinic receptors. Unlike acetylcholine, bethanechol is not hydrolyzed by cholinesterase and will therefore have a long duration of action. Bethanechol is sold under the brand names Duvoid (Roberts), Myotonachol (Glenwood), Urecholine (Merck Frosst), and Urocarb (Hamilton). The name bethanechol refers to its structure as the urethane of beta-methylcholine.